Triple-Therapy Combo Decreases COPD Exacerbations Triple-Therapy Combo Decreases COPD Exacerbations

The combination of an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2 agonist improves control of COPD exacerbations, findings from a phase 3 trial show.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news